Xeris Pharmaceuticals | XERS - DÍVIDA





DÍVIDA Alterar Data
Celltrion KRW 161.31B 9.78B 2025-12
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.28M 45K 2025-09
Divis Laboratories Ltd INR 40M 40M 2025-03
Eli Lilly USD 42.5B 3.6M 2025-12
Kangmei Pharma CNY 131.64M 90.18M 2025-06
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Nektar Therapeutics USD 0 0 2022-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Ovoca Bio EUR 0 0 2021-06
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.64B 4.5M 2025-12
Pharma Mar EUR 47.54M 1.88M 2026-03
Qiagen NV USD 1.81B 314.82M 2025-12
Sartorius EUR 4.28B 372.9M 2025-12
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Supernus Pharmaceuticals USD 40.98M 1.23M 2025-12
Tilray USD 640.95M 35.17M 2022-06
Zz Pientze Pharmaceu CNY 1.07B 2.82M 2026-03